Estrogen receptor-beta agonist diarylpropionitrile counteracts the estrogenic activity of estrogen receptor-alpha agonist propylpyrazole-triol in the mammary gland of ovariectomized Sprague Dawley rats

Journal of Steroid Biochemistry and Molecular Biology

Volumn 130, Issue 1-2, 2012, Pages 26-35

  Song, Xiaozheng ^a   Pan, Zhong Zong ^a  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

Author keywords

Breast cancer; Diarylpropionitrile; Estrogen receptor; Hormone replacement therapy; Mammary gland; Propylpyrazole triol

Indexed keywords

1,3,5 TRIS(4 HYDROXYPHENYL) 4 PROPYLPYRAZOLE; AMPHIREGULIN; DIARYLPROPIONITRILE; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; PROGESTERONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING AFFINITY; CANCER RISK; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENDOMETRIUM CELL; ESTROGEN ACTIVITY; FEMALE; GENE EXPRESSION; IN VIVO STUDY; MAMMARY GLAND; NONHUMAN; OVARIECTOMY; RANDOMIZED CONTROLLED TRIAL; RAT; REAL TIME POLYMERASE CHAIN REACTION; UTERUS;

ANIMALS; CELL PROLIFERATION; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FEMALE; IMMUNOHISTOCHEMISTRY; MAMMARY GLANDS, ANIMAL; NITRILES; OVARIECTOMY; PROPIONATES; PYRAZOLES; RATS; RATS, SPRAGUE-DAWLEY;

RATTUS;

EID: 84859231376     PISSN: 09600760     EISSN: 18791220     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2011.12.018     Document Type: Article

References (74)

1. V. Beral, E. Banks, S. Bull, and E. Reeves Breast cancer and hormone-replacement therapy in the Million Women Study Lancet 362 2003 419 427 (Pubitemid 36999703)
2. J.E. Rossouw, G.L. Anderson, R.L. Prentice, A.Z. LaCroix, C. Kooperberg, M.L. Stefanick, R.D. Jackson, S.A. Beresford, B.V. Howard, K.C. Johnson, J.M. Kotchen, and J. Ockene Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results. From the Women's Health Initiative randomized controlled trial JAMA 288 2002 321 333 (Pubitemid 34761611)
3. I. Persson, E. Weiderpass, L. Bergkvist, R. Bergstrom, and C. Schairer Risks of breast and endometrial cancer after estrogen and estrogen-progestin replacement Cancer Causes Control 10 1999 253 260 (Pubitemid 29358958)
4. M.C. Pike, and R.K. Ross Progestins and menopause: epidemiological studies of risks of endometrial and breast cancer Steroids 65 2000 659 664
5. C. Schairer, J. Lubin, R. Troisi, S. Sturgeon, L. Brinton, and R. Hoover Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk JAMA 283 2000 485 491 (Pubitemid 30062864)
6. R.K. Ross, A. Paganini-Hill, P.C. Wan, and M.C. Pike Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin J. Natl. Cancer Inst. 92 2000 328 332 (Pubitemid 30117736)
7. J.F. Couse, and K.S. Korach Estrogen receptor null mice: what have we learned and where will they lead us? Endocr. Rev. 20 1999 358 417 (Pubitemid 30654784)
8. S. Dupont, A. Krust, A. Gansmuller, A. Dierich, P. Chambon, and M. Mark Effect of single and compound knockouts of estrogen receptors alpha (ERalpha) and beta (ERbeta) on mouse reproductive phenotypes Development 127 2000 4277 4291
9. H.A. Harris Estrogen receptor-beta: recent lessons from in vivo studies Mol. Endocrinol. 21 2007 1 13 (Pubitemid 46041687)
10. M.H. Herynk, and S.A. Fuqua Estrogen receptor mutations in human disease Endocr. Rev. 25 2004 869 898 (Pubitemid 39657771)
11. S. Mallepell, A. Krust, P. Chambon, and C. Brisken Paracrine signaling through the epithelial estrogen receptor alpha is required for proliferation and morphogenesis in the mammary gland Proc. Natl. Acad. Sci. U.S.A. 103 2006 2196 2201 (Pubitemid 43271646)
12. G.G. Kuiper, B. Carlsson, K. Grandien, E. Enmark, J. Haggblad, S. Nilsson, and J.A. Gustafsson Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta Endocrinology 138 1997 863 870 (Pubitemid 27089735)
13. G. Ferrandina, F.O. Ranelletti, V. Gallotta, E. Martinelli, G.F. Zannoni, M. Gessi, and G. Scambia Expression of cyclooxygenase-2 (COX-2), receptors for estrogen (ER), and progesterone (PR) p53, ki67, and neu protein in endometrial cancer, Gynecol. Oncol. 98 2005 383 389 (Pubitemid 41169148)
14. M.M. Regan, G. Viale, M.G. Mastropasqua, E. Maiorano, R. Golouh, A. Carbone, B. Brown, M. Suurkula, G. Langman, L. Mazzucchelli, S. Braye, P. Grigolato, R.D. Gelber, M. Castiglione-Gertsch, K.N. Price, A.S. Coates, A. Goldhirsch, and B. Gusterson Re-evaluating adjuvant breast cancer trials: assessing hormone receptor status by immunohistochemical versus extraction assays J. Natl. Cancer Inst. 98 2006 1571 1581 (Pubitemid 44680908)
15. R.B. Clarke, A. Howell, C.S. Potten, and E. Anderson Dissociation between steroid receptor expression and cell proliferation in the human breast Cancer Res. 57 1997 4987 4991 (Pubitemid 27498105)
16. J. Russo, X. Ao, C. Grill, and I.H. Russo Pattern of distribution of cells positive for estrogen receptor alpha and progesterone receptor in relation to proliferating cells in the mammary gland Breast Cancer Res. Treat. 53 1999 217 227 (Pubitemid 29209891)
17. B.S. Shoker, C. Jarvis, D.R. Sibson, C. Walker, and J.P. Sloane Oestrogen receptor expression in the normal and pre-cancerous breast J. Pathol. 188 1999 237 244 (Pubitemid 29317764)
18. G. Cheng, Y. Li, Y. Omoto, Y. Wang, T. Berg, M. Nord, P. Vihko, M. Warner, Y.S. Piao, and J.A. Gustafsson Differential regulation of estrogen receptor (ER)alpha and ERbeta in primate mammary gland J. Clin. Endocrinol. Metab. 90 2005 435 444 (Pubitemid 40116692)
19. B.S. Shoker, C. Jarvis, R.B. Clarke, E. Anderson, J. Hewlett, M.P. Davies, D.R. Sibson, and J.P. Sloane Estrogen receptor-positive proliferating cells in the normal and precancerous breast Am. J. Pathol. 155 1999 1811 1815
20. H. Tan, Y. Zhong, and Z. Pan Autocrine regulation of cell proliferation by estrogen receptor-alpha in estrogen receptor-alpha-positive breast cancer cell lines BMC Cancer 9 2009 31
21. J.F. Couse, V.L. Davis, R.B. Hanson, W.N. Jefferson, J.A. McLachlan, B.C. Bullock, R.R. Newbold, and K.S. Korach Accelerated onset of uterine tumors in transgenic mice with aberrant expression of the estrogen receptor after neonatal exposure to diethylstilbestrol Mol. Carcinog. 19 1997 236 242 (Pubitemid 27392002)
22. M.S. Frech, E.D. Halama, M.T. Tilli, B. Singh, E.J. Gunther, L.A. Chodosh, J.A. Flaws, and P.A. Furth Deregulated estrogen receptor alpha expression in mammary epithelial cells of transgenic mice results in the development of ductal carcinoma in situ Cancer Res. 65 2005 681 685 (Pubitemid 40216421)
23. M.T. Tilli, M.S. Frech, M.E. Steed, K.S. Hruska, M.D. Johnson, J.A. Flaws, and P.A. Furth Introduction of estrogen receptor-alpha into the tTA/TAg conditional mouse model precipitates the development of estrogen-responsive mammary adenocarcinoma Am. J. Pathol. 163 2003 1713 1719 (Pubitemid 37310001)
24. C. Forster, S. Makela, A. Warri, S. Kietz, D. Becker, K. Hultenby, M. Warner, and J.A. Gustafsson Involvement of estrogen receptor beta in terminal differentiation of mammary gland epithelium Proc. Natl. Acad. Sci. U.S.A. 99 2002 15578 15583 (Pubitemid 35407484)
25. J.H. Krege, J.B. Hodgin, J.F. Couse, E. Enmark, M. Warner, J.F. Mahler, M. Sar, K.S. Korach, J.A. Gustafsson, and O. Smithies Generation and reproductive phenotypes of mice lacking estrogen receptor beta Proc. Natl. Acad. Sci. U.S.A. 95 1998 15677 15682 (Pubitemid 29018759)
26. I. Girault, C. Andrieu, S. Tozlu, F. Spyratos, I. Bieche, and R. Lidereau Altered expression pattern of alternatively spliced estrogen receptor beta transcripts in breast carcinoma Cancer Lett. 215 2004 101 112 (Pubitemid 39221465)
27. P. Roger, M.E. Sahla, S. Makela, J.A. Gustafsson, P. Baldet, and H. Rochefort Decreased expression of estrogen receptor beta protein in proliferative preinvasive mammary tumors Cancer Res. 61 2001 2537 2541 (Pubitemid 32685835)
28. A.M. Shaaban, P.A. O'Neill, M.P. Davies, R. Sibson, C.R. West, P.H. Smith, and C.S. Foster Declining estrogen receptor-beta expression defines malignant progression of human breast neoplasia Am. J. Surg. Pathol. 27 2003 1502 1512 (Pubitemid 37486611)
29. S.D. Berry, P.M. Jobst, S.E. Ellis, R.D. Howard, A.V. Capuco, and R.M. Akers Mammary epithelial proliferation and estrogen receptor alpha expression in prepubertal heifers: effects of ovariectomy and growth hormone J. Dairy Sci. 86 2003 2098 2105 (Pubitemid 39067072)
30. G. Cheng, Z. Weihua, M. Warner, and J.A. Gustafsson Estrogen receptors ER alpha and ER beta in proliferation in the rodent mammary gland Proc. Natl. Acad. Sci. U.S.A. 101 2004 3739 3746 (Pubitemid 38386631)
31. A. Kariagina, J. Xie, J.R. Leipprandt, and S.Z. Haslam Amphiregulin mediates estrogen, progesterone, and EGFR signaling in the normal rat mammary gland and in hormone-dependent rat mammary cancers Horm. Cancer 1 2010 229 244
32. O.D. Slayden, and R.M. Brenner Hormonal regulation and localization of estrogen, progestin and androgen receptors in the endometrium of nonhuman primates: effects of progesterone receptor antagonists Arch. Histol. Cytol. 67 2004 393 409 (Pubitemid 40417399)
33. L.J. Hofseth, A.M. Raafat, J.R. Osuch, D.R. Pathak, C.A. Slomski, and S.Z. Haslam Hormone replacement therapy with estrogen or estrogen plus medroxyprogesterone acetate is associated with increased epithelial proliferation in the normal postmenopausal breast J. Clin. Endocrinol. Metab. 84 1999 4559 4565
34. D. Hanahan, and R.A. Weinberg The hallmarks of cancer Cell 100 2000 57 70 (Pubitemid 30046295)
35. Z.Z. Pan, and A.K. Godwin ONCOGENES R.A. Meyers, Encyclopedia of Molecular Cell Biology and Molecular Medicine 2005 Wiley-VCH Verlag GmbH & Co, KgaA Weinheim 435 495
36. H.A. Harris, J.A. Katzenellenbogen, and B.S. Katzenellenbogen Characterization of the biological roles of the estrogen receptors ERalpha and ERbeta, in estrogen target tissues in vivo through the use of an ERalpha-selective ligand Endocrinology 143 2002 4172 4177 (Pubitemid 35239546)
37. K.W. Sinkevicius, J.E. Burdette, K. Woloszyn, S.C. Hewitt, K. Hamilton, S.L. Sugg, K.A. Temple, F.E. Wondisford, K.S. Korach, T.K. Woodruff, and G.L. Greene An estrogen receptor-alpha knock-in mutation provides evidence of ligand-independent signaling and allows modulation of ligand-induced pathways in vivo Endocrinology 149 2008 2970 2979 (Pubitemid 351724534)
38. J.Q. Chen, P.A. Russo, C. Cooke, I.H. Russo, and J. Russo ERbeta shifts from mitochondria to nucleus during estrogen-induced neoplastic transformation of human breast epithelial cells and is involved in estrogen-induced synthesis of mitochondrial respiratory chain proteins Biochim. Biophys. Acta 1773 2007 1732 1746 (Pubitemid 350191975)
39. J. Hartman, K. Lindberg, A. Morani, J. Inzunza, A. Strom, and J.A. Gustafsson Estrogen receptor beta inhibits angiogenesis and growth of T47D breast cancer xenografts Cancer Res. 66 2006 11207 11213 (Pubitemid 46009948)
40. L.A. Helguero, M.H. Faulds, J.A. Gustafsson, and L.A. Haldosen Estrogen receptors alfa (ERalpha) and beta (ERbeta) differentially regulate proliferation and apoptosis of the normal murine mammary epithelial cell line HC11 Oncogene 24 2005 6605 6616 (Pubitemid 41486791)
41. G. Lazennec, D. Bresson, A. Lucas, C. Chauveau, and F. Vignon ER beta inhibits proliferation and invasion of breast cancer cells Endocrinology 142 2001 4120 4130 (Pubitemid 32802685)
42. S. Paruthiyil, H. Parmar, V. Kerekatte, G.R. Cunha, G.L. Firestone, and D.C. Leitman Estrogen receptor beta inhibits human breast cancer cell proliferation and tumor formation by causing a G2 cell cycle arrest Cancer Res. 64 2004 423 428 (Pubitemid 38114127)
43. A.M. Sotoca, H. van den Berg, J. Vervoort, P. van der Saag, A. Strom, J.A. Gustafsson, I. Rietjens, and A.J. Murk Influence of cellular ERalpha/ERbeta ratio on the ERalpha-agonist induced proliferation of human T47D breast cancer cells Toxicol. Sci. 105 2008 303 311
44. A. Strom, J. Hartman, J.S. Foster, S. Kietz, J. Wimalasena, and J.A. Gustafsson Estrogen receptor beta inhibits 17beta-estradiol-stimulated proliferation of the breast cancer cell line T47D Proc. Natl. Acad. Sci. U.S.A. 101 2004 1566 1571 (Pubitemid 38236167)
45. O. Treeck, I. Juhasz-Boess, C. Lattrich, F. Horn, R. Goerse, and O. Ortmann Effects of exon-deleted estrogen receptor beta transcript variants on growth, apoptosis and gene expression of human breast cancer cell lines Breast Cancer Res. Treat. 110 2008 507 520 (Pubitemid 351962596)
46. O. Treeck, C. Lattrich, A. Springwald, and O. Ortmann Estrogen receptor beta exerts growth-inhibitory effects on human mammary epithelial cells Breast Cancer Res. Treat. 120 2009 557 565
47. B.J. Deroo, and A.V. Buensuceso Minireview estrogen receptor-beta: mechanistic insights from recent studies Mol. Endocrinol. 24 2010 1703 1714
48. M. Warner, and J.A. Gustafsson The role of estrogen receptor beta (ERbeta) in malignant diseases - a new potential target for antiproliferative drugs in prevention and treatment of cancer Biochem. Biophys. Res. Commun. 396 2010 63 66
49. M.M. Liu, C. Albanese, C.M. Anderson, K. Hilty, P. Webb, R.M. Uht, R.H. Price, R.G. Pestell Jr., and P.J. Kushner Opposing action of estrogen receptors alpha and beta on cyclin D1 gene expression J. Biol. Chem. 277 2002 24353 24360 (Pubitemid 34951956)
50. K. Paech, P. Webb, G.G. Kuiper, S. Nilsson, J. Gustafsson, P.J. Kushner, and T.S. Scanlan Differential ligand activation of estrogen receptors ERalpha and ERbeta at AP1 sites Science 277 1997 1508 1510 (Pubitemid 27449239)
51. J.M. Hall, and D.P. McDonnell The estrogen receptor beta-isoform (ERbeta) of the human estrogen receptor modulates ERalpha transcriptional activity and is a key regulator of the cellular response to estrogens and antiestrogens Endocrinology 140 1999 5566 5578 (Pubitemid 30645344)
52. J. Matthews, and J.A. Gustafsson Estrogen signaling: a subtle balance between ER alpha and ER beta Mol. Interv. 3 2003 281 292
53. H.A. Harris The unexpected science of estrogen receptor-beta selective agonists: a new class of anti-inflammatory agents? Nucl. Recept. Signal 4 2006 e012
54. S. Paruthiyil, A. Cvoro, X. Zhao, Z. Wu, Y. Sui, R.E. Staub, S. Baggett, C.B. Herber, C. Griffin, M. Tagliaferri, H.A. Harris, I. Cohen, L.F. Bjeldanes, T.P. Speed, F. Schaufele, and D.C. Leitman Drug and cell type-specific regulation of genes with different classes of estrogen receptor beta-selective agonists PLoS One 4 2009 e6271
55. F. Minutolo, M. Macchia, B.S. Katzenellenbogen, and J.A. Katzenellenbogen Estrogen receptor beta ligands: recent advances and biomedical applications Med. Res. Rev. 31 2011 364 442
56. J.S. Crabtree, X. Zhang, B.J. Peano, Z. Zhang, R.C. Winneker, and H.A. Harris Development of a mouse model of mammary gland versus uterus tissue selectivity using estrogen- and progesterone-regulated gene markers J. Steroid Biochem. Mol. Biol. 101 2006 11 21 (Pubitemid 44301886)
57. H.A. Harris, L.M. Albert, Y. Leathurby, M.S. Malamas, R.E. Mewshaw, C.P. Miller, Y.P. Kharode, J. Marzolf, B.S. Komm, R.C. Winneker, D.E. Frail, R.A. Henderson, Y. Zhu, and J.C. Keith Jr. Evaluation of an estrogen receptor-beta agonist in animal models of human disease Endocrinology 144 2003 4241 4249 (Pubitemid 37204818)
58. M.J. Meyers, J. Sun, K.E. Carlson, G.A. Marriner, B.S. Katzenellenbogen, and J.A. Katzenellenbogen Estrogen receptor-beta potency-selective ligands: structure-activity relationship studies of diarylpropionitriles and their acetylene and polar analogues J. Med. Chem. 44 2001 4230 4251 (Pubitemid 33095330)
59. S.R. Stauffer, C.J. Coletta, R. Tedesco, G. Nishiguchi, K. Carlson, J. Sun, B.S. Katzenellenbogen, and J.A. Katzenellenbogen Pyrazole ligands: structure-affinity/activity relationships and estrogen receptor-alpha-selective agonists J. Med. Chem. 43 2000 4934 4947 (Pubitemid 32040974)
60. J.E. Sanchez-Criado, J. Martin De Las Mulas, C. Bellido, M. Tena-Sempere, R. Aguilar, and A. Blanco Biological role of pituitary estrogen receptors ERalpha and ERbeta on progesterone receptor expression and action and on gonadotropin and prolactin secretion in the rat Neuroendocrinology 79 2004 247 258 (Pubitemid 38969870)
61. C. Engdahl, C. Jochems, S.H. Windahl, A.E. Borjesson, C. Ohlsson, H. Carlsten, and M.K. Lagerquist Amelioration of collagen-induced arthritis and immune-associated bone loss through signaling via estrogen receptor alpha, and not estrogen receptor beta or G protein-coupled receptor 30 Arthritis Rheum. 62 2010 524 533
62. J. Frasor, D.H. Barnett, J.M. Danes, R. Hess, A.F. Parlow, and B.S. Katzenellenbogen Response-specific and ligand dose-dependent modulation of estrogen receptor (ER) alpha activity by ERbeta in the uterus Endocrinology 144 2003 3159 3166 (Pubitemid 36819918)
63. G.G. Kuiper, J.G. Lemmen, B. Carlsson, J.C. Corton, S.H. Safe, P.T. van der Saag, B. van der Burg, and J.A. Gustafsson Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta Endocrinology 139 1998 4252 4263 (Pubitemid 28513713)
64. J. Li, and R.W. McMurray Effects of estrogen receptor subtype-selective agonists on immune functions in ovariectomized mice Int. Immunopharmacol. 6 2006 1413 1423 (Pubitemid 44038682)
65. A. Bliedtner, O. Zierau, S. Albrecht, S. Liebhaber, and G. Vollmer Effects of genistein and estrogen receptor subtype-specific agonists in ArKO mice following different administration routes Mol. Cell Endocrinol. 314 2010 41 52
66. J. Bowe, X.F. Li, J. Kinsey-Jones, A. Heyerick, S. Brain, S. Milligan, and K. O'Byrne The hop phytoestrogen 8-prenylnaringenin, reverses the ovariectomy-induced rise in skin temperature in an animal model of menopausal hot flushes J. Endocrinol. 191 2006 399 405 (Pubitemid 44830615)
67. I. Nikolic, D. Liu, J.A. Bell, J. Collins, C. Steenbergen, and E. Murphy Treatment with an estrogen receptor-beta-selective agonist is cardioprotective J. Mol. Cell Cardiol. 42 2007 769 780 (Pubitemid 46527602)
68. L. Ciarloni, S. Mallepell, and C. Brisken Amphiregulin is an essential mediator of estrogen receptor alpha function in mammary gland development Proc. Natl. Acad. Sci. U.S.A. 104 2007 5455 5460 (Pubitemid 47175701)
69. I.N. Wegorzewska, K. Walters, M.J. Weiser, D.F. Cruthirds, E. Ewell, D.O. Larco, R.J. Handa, and T.J. Wu Postovariectomy weight gain in female rats is reversed by estrogen receptor alpha agonist, propylpyrazoletriol Am. J. Obstet. Gynecol. 199 2008 67, e61-65
70. R.B. Clarke Steroid receptors and proliferation in the human breast Steroids 68 2003 789 794 (Pubitemid 37532401)
71. F. de Waard, and J.H. Thijssen Hormonal aspects in the causation of human breast cancer: epidemiological hypotheses reviewed, with special reference to nutritional status and first pregnancy J. Steroid Biochem. Mol. Biol. 97 2005 451 458 (Pubitemid 41691886)
72. I.H. Russo, and J. Russo Role of hormones in mammary cancer initiation and progression J. Mammary Gland Biol. Neoplasia 3 1998 49 61 (Pubitemid 128513219)
73. E.K. Shanle, and W. Xu Endocrine disrupting chemicals targeting estrogen receptor signaling: identification and mechanisms of action Chem. Res. Toxicol. 24 2011 6 19
74. V.C. Jordan, and A.M. Brodie Development and evolution of therapies targeted to the estrogen receptor for the treatment and prevention of breast cancer Steroids 72 2007 7 25 (Pubitemid 46037765)